MedEquities Realty Trust (MRT) Price Target Cut to $12.00 by Analysts at KeyCorp

MedEquities Realty Trust (NYSE:MRT) had its price objective lowered by research analysts at KeyCorp from $13.00 to $12.00 in a research note issued to investors on Monday. The firm currently has an “overweight” rating on the financial services provider’s stock. KeyCorp’s price objective indicates a potential upside of 17.99% from the company’s previous close.

Several other brokerages also recently issued reports on MRT. Zacks Investment Research downgraded MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Citigroup cut their price target on MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Thursday, March 1st. ValuEngine downgraded MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $14.00 price target on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. Finally, B. Riley set a $13.00 price objective on MedEquities Realty Trust and gave the stock a “buy” rating in a research report on Thursday, February 22nd. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $12.33.

How to Become a New Pot Stock Millionaire

MedEquities Realty Trust stock traded down $0.05 during mid-day trading on Monday, hitting $10.17. 46,198 shares of the company’s stock traded hands, compared to its average volume of 160,547. MedEquities Realty Trust has a fifty-two week low of $9.67 and a fifty-two week high of $13.06. The company has a market capitalization of $322.37, a price-to-earnings ratio of 8.96 and a beta of -0.21.

MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings results on Wednesday, February 21st. The financial services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.13). MedEquities Realty Trust had a net margin of 34.96% and a return on equity of 5.99%. The business had revenue of $16.23 million for the quarter, compared to analyst estimates of $16.31 million. During the same period in the prior year, the business earned ($0.06) EPS. The company’s revenue for the quarter was up 13.8% compared to the same quarter last year. sell-side analysts expect that MedEquities Realty Trust will post 1.21 EPS for the current year.

Hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN increased its position in shares of MedEquities Realty Trust by 43.4% in the third quarter. Wells Fargo & Company MN now owns 35,366 shares of the financial services provider’s stock worth $416,000 after purchasing an additional 10,700 shares during the period. Raymond James Financial Services Advisors Inc. increased its position in shares of MedEquities Realty Trust by 89.0% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 25,012 shares of the financial services provider’s stock worth $281,000 after purchasing an additional 11,778 shares during the period. Martingale Asset Management L P increased its position in shares of MedEquities Realty Trust by 28.3% in the fourth quarter. Martingale Asset Management L P now owns 253,701 shares of the financial services provider’s stock worth $2,847,000 after purchasing an additional 55,937 shares during the period. Eagle Boston Investment Management Inc. increased its position in shares of MedEquities Realty Trust by 4.6% in the fourth quarter. Eagle Boston Investment Management Inc. now owns 732,664 shares of the financial services provider’s stock worth $8,220,000 after purchasing an additional 32,140 shares during the period. Finally, Asset Management One Co. Ltd. increased its position in shares of MedEquities Realty Trust by 40.8% in the third quarter. Asset Management One Co. Ltd. now owns 62,539 shares of the financial services provider’s stock worth $747,000 after purchasing an additional 18,111 shares during the period. Hedge funds and other institutional investors own 92.78% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/17/medequities-realty-trust-mrt-given-a-12-00-price-target-at-keycorp.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply